Abstract
Suicide is the tenth leading cause of death in Americans of all ages. Presence of a chronic medical illness (e.g. Diabetes mellitus) increases the risk of suicide. The goal of this review is to examine the relationship between diabetes and depression, as well as diabetes and suicide. Earlier this year, the U.S. Preventive Task Force (USPTF) escalated their recommendation for depression to include not only routine screening for depression but additional focus on active follow up that requires measurement based care. As a result, it is important that persons with diabetes are also screened for suicidal ideation in the presence of a mood disorder. Due to the higher risk and access to potentially lethal medications in persons with diabetes, risk mitigation procedures should be in place that includes not only depression and suicide screening but also the use of inter-disciplinary teams. Appropriate medical monitoring is essential following a suicide attempt to avoid death particularly because these patients are prone to repeat attempts.
Keywords: Depression, diabetes, insulin pump, suicide attempt, overdose.
Current Diabetes Reviews
Title:Death by Insulin: Management of Self-Harm and Suicide in Diabetes Management
Volume: 13 Issue: 3
Author(s): Alyson K. Myers*Madhukar H. Trivedi
Affiliation:
- North Shore University Hospital and Assistant Professor Hofstra Northwell School of Medicine, Hempstead, NY, 300 Community Drive, Manhasset, NY, 11030,United States
Keywords: Depression, diabetes, insulin pump, suicide attempt, overdose.
Abstract: Suicide is the tenth leading cause of death in Americans of all ages. Presence of a chronic medical illness (e.g. Diabetes mellitus) increases the risk of suicide. The goal of this review is to examine the relationship between diabetes and depression, as well as diabetes and suicide. Earlier this year, the U.S. Preventive Task Force (USPTF) escalated their recommendation for depression to include not only routine screening for depression but additional focus on active follow up that requires measurement based care. As a result, it is important that persons with diabetes are also screened for suicidal ideation in the presence of a mood disorder. Due to the higher risk and access to potentially lethal medications in persons with diabetes, risk mitigation procedures should be in place that includes not only depression and suicide screening but also the use of inter-disciplinary teams. Appropriate medical monitoring is essential following a suicide attempt to avoid death particularly because these patients are prone to repeat attempts.
Export Options
About this article
Cite this article as:
Myers K. Alyson*, Trivedi H. Madhukar, Death by Insulin: Management of Self-Harm and Suicide in Diabetes Management, Current Diabetes Reviews 2017; 13 (3) . https://dx.doi.org/10.2174/1573399812666161005163618
DOI https://dx.doi.org/10.2174/1573399812666161005163618 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial [Hot topic: New Developments in the Treatment and Prevention of Vascular Disease - Part 1 (Executive Editors: N. Katsiki, V.G. Athyros and D.P. Mikhailidis)]
Current Pharmaceutical Design Mesenchymal Stromal Cells from Umbilical Cord Blood
Current Stem Cell Research & Therapy Protein-Tyrosine Phosphatase 1B (PTP1B): A Novel Therapeutic Target for Type 2 Diabetes Mellitus, Obesity and Related States of Insulin Resistance
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Discovery Approaches for Novel Dyslipidemia Drugs
Current Drug Discovery Technologies Disorders of Mineral Metabolism in the Newborn
Current Pediatric Reviews MicroRNA Dysregulation in Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Conduction Disorders: The Value of Surface ECG
Current Cardiology Reviews Is Later Obesity Programmed In Utero?
Current Drug Targets Assessment of Glomerular and Tubular Function
Current Pediatric Reviews Role of Vascular Endothelial Growth Factor in Kidney Disease
Current Vascular Pharmacology Personalized Medicine, Bioethics and Social Responsibilities: Re-thinking the Pharmaceutical Industry to Remedy Inequities in Patient Care and International Health
Current Pharmacogenomics and Personalized Medicine Quality of Life of Children with Type 1 Diabetes: A Systematic Review
Current Diabetes Reviews Enhancement of the Pharmacological Efficacy of FGF-21 by Genetic Modification and PEGylation
Current Pharmaceutical Biotechnology Mitochondria in Chronic Liver Disease
Current Drug Targets Breast Cancer: Biological Characteristics in Postmenopausal Type 2 Diabetic Women. Identification of Therapeutic Targets
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Regulatory Role of Heat Shock Proteins in the Pathogenesis of Type 1 and Type 2 Diabetes
Current Immunology Reviews (Discontinued) Diagnosis and Treatment of Dyslipidaemias in Athletes
Current Vascular Pharmacology Coffee to Reduce Risk of Type 2 Diabetes? : A Systematic Review
Current Diabetes Reviews Editorial (Thematic Issue Title: Myocardial Cell Death: Molecular Mechanisms & Drug Targets)
Cardiovascular & Hematological Agents in Medicinal Chemistry A Review on Cellular and Molecular Mechanisms Linked to the Development of Diabetes Complications
Current Diabetes Reviews